Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide

Manhattan Medical Research, New York

Novel Research of New York, The Bronx

Carteret Medical Group, LLC, Morehead City

Care Partners Clinical Research, LLC, Jacksonville

International Research Associates, LLC, Hialeah

AMPM Research Clinic, Miami

Epocrates Medical and Research Center, Miami

Meridien Research, Brooksville

Sensible Healthcare, LLC, Ocoee

Alabama Clinical Therapeutics, LLC, Birmingham

Saint Vincent's Medical Center (BRANY), Gulf Shores

University of Tennessee Health Sciences Center, Memphis

Prestige Clinical Research, Franklin

American Health Network of Indiana, LLC, Avon

American Health Network of Indiana, LLC, Franklin

American Health Network of Indiana, LLC, Greenfield

Radiant Research, St Louis

Center for Advanced Medical Research, City of Saint Peters

Cotton-O'Neil Clinical Research Center, Topeka

Arkansas Primary Care Clinic, PA, Little Rock

Lynn Institute of the Oz, Norman

LION Research, Norman

Dallas Diabetes and Endocrine Center, Dallas

Juno Research, LLC, Houston

Sante Clinical Research, Kerrville

Panacea Clinical Research, LLC, San Antonio

Clinical Trials of Texas, Inc., San Antonio

Victorium Clinical Research Ltd., San Antonio

Coastal Bend Clinical Research, Corpus Christi

Denver VA Medical Center, Denver

Solaris Clinical Research, Meridian

Erickson Research and Development, Clinton

Accent Clinical Trials, Las Vegas

Palm Research Center, Inc., Las Vegas

University of Colorado Hospital, Aurora

University of Massachusetts Medical School, Worcester